Table 1.
TBEV | Confirmed Infection | CPE | Cell Death | Effect on Blood–Brain Barrier | Chemokines/Cytokines | Traffic of Endosomes | Reference |
---|---|---|---|---|---|---|---|
Primary human astrocytes | + | + | +/− | + | + | N/A | [31] |
Primary mouse astrocytes | + | + | + (IFNAR knockout) | N/A | + | N/A | [32,56] |
Primary rat astrocytes | + | − | − | N/A | N/A | + | [19] |
Glioblastoma cell line | + | + | + | N/A | N/A | N/A | [18] |
Human brain | + | + | + | N/A | N/A | N/A | [57] |
Mouse, vole, shrew brain | + | N/A | N/A | + | + | N/A | [39,40,50,52] |
CPE, extensive morphologic changes in the cytoplasm/cytopathogenic effect. Chemokines/cytokines, detected release of chemokines and cytokines from astrocytes. IFNAR, IFNα/β receptor; N/A, not applicable (not reported); +, the effect or upregulation was detected; −, the effect was absent; +/−, both effects observed.